cardiac-catheterization
Diseases Process
Instructed to store NTG in cool, dark place, in tightly closed container. To assure freshness replace supply of sublingual tablets every 3 months.
Taught that history of diabetes, cardiac disease and renal disease are potential factors of cerebrovascular accident (stroke).
Taught that heart failure, cardiac arrest and dysrhythmias are potential complications of Coronary Artery Disease (CAD).
SN instructed patient and caregiver that dysrhythmias of the heart and myocardial infarction may constitute as potential complications of Angina Pectoris. Cardiac arrhythmia occurs when electrical impulses in the heart do not work properly. A heart attack usually occurs when a blood clot blocks blood flow to the heart. Angina is a symptom of coronary artery disease. Patient verbalized understanding.
Taught that stopping activity immediately if cardiac symptoms (e.g., chest pain, increased shortness of breath and/or excessive fatigue) occur is a measure aimed to increasing tolerance in response to increased physical activity.
Instructed patient to store NTG in a cool, dark place, in a tightly closed container (this will assure freshness). Replace supply of sublingual tablets every 3 months.
Instructed patient about S/S complications associated with CHF, including bounding pulse, decreased urinary output, increased SOB, increased edema and sudden weight gain.
The patient was instructed in coronary artery disease the importance of no smoking or using tobacco products, the effect nicotine has on the cardiac system causing the heart to work faster, constricting blood vessels, and decreasing the amount of oxygen delivered to the heart, and in the presence of coronary artery disease, increasing the probability of chest pain. The patient was advised that the role that stress plays in aggravating coronary artery disease. The patient was recommended the benefits of exercise, increase in high-density lipoproteins, which lowers blood pressure, weight loss, improved cardiovascular status.
SN instructed about the Lifevest wearable defibrillator . Is a treatment option for sudden cardiac arrest that offers patients advanced protection and monitoring as well as improved quality of life. The Lifevest is the first wearable defibrillator. Unlike an implantable cardioverter defibrillator ( ICD ), the Lifevest is worn outside the body rather than implanted in the chest. This device continuously monitors the patient's heart with dry, non-adhesive sensing electrodes to detect life - threatening abnormal heart rhythms. If a life - threatening rhythm is detected, the device alerts the patient prior to delivering a treatment shock, and thus allows a conscious patient to delay the treatment shock. If the patient becomes unconscious, the device releases a Blue™ gel over the therapy electrodes and delivers an electrical shock to restore normal rhythm.
Instructed patient her LVAD team will give you detailed instructions on what you need to do on a daily basis for your specific device and medical condition. They will also most likely give you a chart (sometimes called a “flowsheet”) customized for your specific device, to fill out daily. Flowsheets make it easy to keep track of your weight, medications, device settings (such as pump speed, power, etc.) and other daily maintenance items. Sample flowsheets are included at the bottom of the page (they vary slightly based on manufacturer). It is a sample only; use the flowsheet provided by your LVAD team. Understanding was verbalized.